Antimicrobial Resistance

© Getty Images

Shionogi acquires QPex to harness antimicrobial pipeline

By Jonathan Smith

The Japanese company Shionogi has taken over the US biotech Qpex Biopharma for up to $140 million in a bid to expand its pipeline of antimicrobial drugs and boost its R&D muscle in infectious disease.

Overreliance on antibiotics in farming has contributed to the problem of antimicrobial resistance

Antibiotics: urgent calls for global payment pot

By Fiona BARRY

As World Antibiotics Awareness Week draws attention to the threat of resistance, pharma companies large and small say a worldwide overhaul of payment models will make anti-infective R&D profitable again.

Spotlight

Follow us

Webinars

Featured Suppliers

All